Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |